Hypercoagulopathy with piperacillin administration in osteomyelitis

6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

A 51-year-old man with osteomyelitis developed acute renal failure and superior mesenteric venous (SMV) thrombosis after piperacillin (PIPC) treatment. Coagulation profile disclosed disseminated intravascular coagulation (DIC). The serum levels of IgE and eosinophil cationic protein showed significant increases, while a lymphocyte stimulation test with PIPC also demonstrated an extremely high index. These observations suggest that hypersensitivity to PIPC might play a role in the pathogenesis of acute renal failure and SMV thrombosis due to hypercoagulopathy. Withdrawal of PIPC and anticoagulation therapy resulted in clinical improvement and normalization of the affected laboratory data. This is the first report to describe PIPC- induced hypercoagulopathy.

Cite

CITATION STYLE

APA

Miyazaki, H., Yanagitani, S., Matsumoto, T., Yoshida, K., Amoh, Y., Watanabe, T., … Inoue, K. (2000). Hypercoagulopathy with piperacillin administration in osteomyelitis. Internal Medicine, 39(5), 424–427. https://doi.org/10.2169/internalmedicine.39.424

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free